IP Library Granted Patent US 10,183,135
Granted Patent B2
US 10,183,135 · App. 14/482,445 · Granted Jan 22, 2019

Zero pressure start continuous positive airway pressure therapy

Inventors: Samir S. Ahmad (San Diego, CA); Leonardo Alberto Baloa-Welzien (Lake Forest, CA)
Assignee: Breathe Technologies, Inc.
A61M16/0069A61M16/0003A61M16/0051A61M16/024A61M16/06A61M16/107A61M2016/0027A61M2205/3344A61M2205/42A61M2205/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,183,135
App. No.
14/482,445
Granted
Jan 22, 2019
Kind
B2
Abstract

A respiratory assistance device is disclosed. There is a patient interface for coupling to a patient respiratory passageway, and a selectively regulated therapeutic gas flow source in pneumatic communication with the patient over the patient interface. A controller is connected to the therapeutic gas flow source and is receptive to inputs of a prescription pressure level and an initial delay duration. After the patient dons the patient interface, therapeutic gas flow is restricted for the initial delay duration following receipt of a treatment initiation command. Upon the expiry of the initial delay duration, the controller increases therapeutic gas flow to the prescription pressure level.

Claims (27)

1. A respiratory assistance device, comprising:

a patient interface for coupling to a respiratory passageway of a patient;

a selectively regulated therapeutic gas source in pneumatic communication with the patient over the patient interface; and

a controller connected to the therapeutic gas source and receptive to inputs of a prescription pressure level and an initial delay duration, delivery of therapeutic gas from the therapeutic gas source being restricted for the initial delay duration following receipt of a treatment initiation command, followed by an increase in therapeutic pressure to the prescription pressure level;

wherein the increase in the therapeutic pressure to the prescription pressure level is controlled over a predetermined ramp duration;

wherein the therapeutic pressure is increased to a ramp base pressure level by the controller after expiration of the initial delay duration, the increase in the therapeutic pressure to the prescription pressure level beginning at the ramp base pressure level;

wherein the therapeutic pressure is maintained at the ramp base pressure level by the controller after expiration of the initial delay duration for a ramp delay duration, the ramp delay duration being a predetermined amount of time adjustable by a user.

2. The respiratory assistance device of claim 1 , wherein the patient interface includes a piloted exhalation valve that permits airflow to and from the respiratory passageway associated with spontaneous breathing while the delivery of therapeutic gas is being restricted.

3. The respiratory assistance device of claim 1 , further comprising:

a first pressure sensor in fluid communication with the patient interface; and

a second pressure sensor in fluid communication with an output of the selectively regulated therapeutic gas source.

4. An article of manufacture comprising a program storage medium readable by a data processing apparatus, the medium tangibly embodying one or more programs of instructions executable by the data processing apparatus to perform a method for delivering therapeutic gas to a patient with a respiratory assistance device, the method comprising:

receiving from the respiratory assistance device a prescription pressure level and a numeric value corresponding to a zero pressure delay duration;

receiving from the respiratory assistance device a treatment initiation command following the patient being pneumatically coupled to the respiratory assistance device over a patient interface;

restricting gas delivery from the respiratory assistance device to the patient interface at a zero pressure level for the zero pressure delay duration in response to receiving the treatment initiation command; and

initiating gas delivery from the respiratory assistance device to the patient interface at the prescription pressure level after expiration of the zero pressure delay duration;

wherein the gas delivery to the patient interface after expiration of the zero pressure delay duration is gradually increased to the prescription pressure level over a ramp duration based upon a ramp function;

wherein gas delivery to the patient interface is increased to a ramp base pressure level after expiration of the zero pressure delay duration;

wherein gas delivery to the patient interface is maintained at the ramp base pressure level after expiration of the zero pressure delay duration for a ramp delay duration, the ramp delay duration being a predetermined amount of time adjustable by a user.

5. The article of manufacture of claim 4 , wherein the zero pressure delay duration corresponds to a predetermined time period for the patient to enter a sleep state.

6. The article of manufacture of claim 4 , wherein the method further comprises:

receiving from the respiratory assistance device a numeric value corresponding to the ramp duration.

7. The article of manufacture of claim 4 , wherein the method further comprises:

receiving from the respiratory assistance device a numeric value corresponding to the ramp delay duration.

8. A system comprising:

the article of manufacture of claim 4 ; and

the patient interface, wherein the patient interface includes a piloted exhalation valve through which the patient inhales and exhales spontaneously while gas delivery from the respiratory assistance device is restricted during the zero pressure delay duration.

Assignments (8)
RELEASE OF SECURITY INTEREST (DATED OCTOBER 11, 2019) Recorded Dec 14, 2021
From: JPMORGAN CHASE BANK, N.A.
To: BREATHE TECHNOLOGIES, INC.; HILL-ROM SERVICES, INC.; ALLEN MEDICAL SYSTEMS, INC.; WELCH ALLYN, INC.; HILL-ROM, INC.; VOALTE, INC.; BARDY DIAGNOSTICS, INC.; HILL-ROM HOLDINGS, INC.
Reel/Frame 058516/0001 →
RELEASE OF SECURITY INTEREST Recorded Sep 9, 2019
From: SOLAR CAPITAL LTD.
To: BREATHE TECHNOLOGIES, INC.
Reel/Frame 050314/0707 →
TERMINATION OF PATENT SECURITY AGREEMENT Recorded Mar 1, 2018
From: SOLAR CAPITAL LTD.
To: BREATHE TECHNOLOGIES, INC.
Reel/Frame 045484/0302 →
SECURITY INTEREST Recorded Jan 8, 2018
From: BREATHE TECHNOLOGIES, INC.
To: SOLAR CAPITAL LTD.
Reel/Frame 045020/0420 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2017
From: BALOA-WELZIEN, LEONARDO ALBERTO
To: BREATHE TECHNOLOGIES, INC.
Reel/Frame 043897/0891 →
MERGER Recorded Mar 24, 2017
From: BREATHE TECHNOLOGIES, INC.
To: BREATHE TECHNOLOGIES, INC.
Reel/Frame 041735/0581 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 20, 2017
From: AHMAD, SAMIR S.
To: BREATHE TECHNOLOGIES, INC.
Reel/Frame 041647/0389 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Dec 29, 2016
From: BREATHE TECHNOLOGIES, INC.
To: SOLAR CAPITAL LTD.
Reel/Frame 041222/0174 →
Continuity (3)
Provisional Application 61876127 · Sep 10, 2013
Provisional Application 61881360 · Sep 23, 2013
Related Publication 20150068529A1 · Mar 12, 2015